A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease

Diego J Laderach, Lucas D Gentilini, Laura Giribaldi, Victor Cardenas Delgado, Lorena Nugnes, Diego O Croci, Nader Al Nakouzi, Paula Sacca, Gabriel Casas, Osvaldo Mazza, Margaret A Shipp, Elba Vazquez, Anne Chauchereau, Jeffery L Kutok, Scott J Rodig, María T Elola, Daniel Compagno, Gabriel A Rabinovich

Cancer Res. 2013 Jan 1;73(1):86-96. doi: 10.1158/0008-5472.CAN-12-1260. Epub 2012 Oct 29